Heather R. Johnson is a freelance writer based in Oakland, CA.
Abbott Laboratories presented some disappointing data for its bioresorbable stent program at TCT, but it was a different story for Reva Medical's scaffold.
With more investments and potential device clearances on the way, the Bioelectronics market is beginning to take off.
A University of California, San Francisco program provides the infrastructure for surgeons to innovate.
As regulatory burdens in Europe have grown, FDA has taken steps toward streamlining. But do efforts aimed at expedited review represent progress or empty promises?
A new wave of breast pump manufacturers is challenging industry leaders with smart, compact, user-friendly designs.
Diabetes presents a huge market for medical device makers, but challenges such as a tough competitive landscape and relatively low profit margins make it anything but a sure bet.
Despite the ongoing opioid crisis in the United States, guidelines don’t list alternative device therapies such as neurostimulators as options for treating chronic pain. What gives?
InTouch Health's TruClinic acquisition mirrors other partnerships in the telehealth space that seek to set the sector up for broader adoption.
The new startup, called Qrativ, combines Mayo Clinic's clinical expertise with artificial intelligence technology to discover treatments for the untreatable.